Nuvama

Rediff.com » News » Nuvama

News for Nuvama

Business

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......

O2C biz may drag RIL to another weak quarter

For Reliance Industries Ltd (RIL), the September 2024 quarter (Q2FY25) may turn out to be yet another weak one as refining margins drag, say analysts. Photograph: ANI Photo Two brokerage firms......

Emami has built itself through acquisition, but...

Two young men jostle in a rickshaw as it clatters along a narrow, bustling lane of North Kolkata, each with a leg dangling over the side of the vehicle, a bulging sack of cosmetics nestled between......

Crompton Greaves Consumer may underperform on demand concerns

The stock of Crompton Greaves Consumer Electricals has shed about 12 per cent since the start of the month due to a muted near-term outlook. Demand slowdown across segments and pre-buying in......

IT aims for the sky after Accenture's Q4 results

Global firm Accenture’s fourth quarter results prove that the worst is behind for the Indian information technology (IT) sector, said analysts on Friday (September 27). Photograph: Dado......

Rediff News

Nuvama

News for Nuvama

Lower input costs may aid pharma firms' Q2 margins

O2C biz may drag RIL to another weak quarter

Emami has built itself through acquisition, but...

Crompton Greaves Consumer may underperform on demand concerns

IT aims for the sky after Accenture's Q4 results

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS